Literature DB >> 1688749

Increased urinary excretion of transferrin in children with type 1 diabetes mellitus.

P Martin1, C Walton, C Chapman, H J Bodansky, M H Stickland.   

Abstract

Urinary transferrin excretion was measured by radioimmunoassay in 74 children with Type 1 diabetes mellitus and in 40 normal children, and compared with urinary excretion of albumin, alpha-1-microglobulin, and N-acetyl-beta-D-glucosaminidase. Urinary transferrin excretion was significantly elevated in diabetic (median (range) 186 (18-1671) mg mol-creatinine-1) compared with normal (85 (27-668) mg mol-creatinine-1) children (p less than 0.001). Seventeen diabetic children had transferrin excretion above the 95th centile for normal children. In contrast there was no significant increase in urinary albumin excretion in the diabetic children although 8 had urinary albumin excretion which exceeded the 95th centile for normal children (6 of these 8 patients having coexistent urinary hyperexcretion of transferrin). Urinary transferrin excretion correlated significantly with urinary albumin excretion in both normal (rs = 0.62, p less than 0.001) and diabetic (rs = 0.61, p less than 0.001) children. The indices of proximal renal tubular function (urinary excretion of alpha-1-microglobulin and N-acetyl-beta-D-glucosaminidase) correlated significantly with transferrin excretion in both diabetic (rs = 0.43 and rs = 0.41, p less than 0.001) and normal (rs = 0.40, p less than 0.02 and rs = 0.53, p less than 0.001) children, but not with albumin excretion (rs = 0.20, p greater than 0.05 and rs = 0.22, p greater than 0.05). In addition urinary transferrin excretion significantly correlated with urinary glucose concentration (rs = 0.34, p less than 0.007) in Type 1 diabetic children. The discrepancy in urinary excretion of transferrin and albumin may reflect impaired proximal renal tubular reabsorption of transferrin and/or altered glomerular basement membrane selectivity for the two proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1688749     DOI: 10.1111/j.1464-5491.1990.tb01304.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  7 in total

1.  Urinary excretion of albumin and transferrin in lithium maintenance treatment: daily versus alternate-day lithium dosing schedule.

Authors:  H V Jensen; J Holm; K Davidsen; L Toftegaard; H Aggernaes; N Bjørum
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

Review 2.  Urinary biomarkers for early diabetic nephropathy: beyond albuminuria.

Authors:  So-Young Lee; Mary E Choi
Journal:  Pediatr Nephrol       Date:  2014-07-25       Impact factor: 3.714

3.  Beta 2-glycoprotein-1 (apolipoprotein H) excretion and renal tubular malfunction in diabetic patients without clinical proteinuria.

Authors:  M Lapsley; F V Flynn; P A Sansom
Journal:  J Clin Pathol       Date:  1993-05       Impact factor: 3.411

4.  Application of proteomics in the discovery of candidate protein biomarkers in a diabetes autoantibody standardization program sample subset.

Authors:  Thomas O Metz; Wei-Jun Qian; Jon M Jacobs; Marina A Gritsenko; Ronald J Moore; Ashoka D Polpitiya; Matthew E Monroe; David G Camp; Patricia W Mueller; Richard D Smith
Journal:  J Proteome Res       Date:  2007-12-20       Impact factor: 4.466

5.  Urinary markers of glomerular injury in diabetic nephropathy.

Authors:  Abraham Cohen-Bucay; Gautham Viswanathan
Journal:  Int J Nephrol       Date:  2012-05-08

Review 6.  Acute phase reactants as novel predictors of cardiovascular disease.

Authors:  M S Ahmed; A B Jadhav; A Hassan; Qing H Meng
Journal:  ISRN Inflamm       Date:  2012-05-06

Review 7.  The role of novel biomarkers in predicting diabetic nephropathy: a review.

Authors:  Samuel N Uwaezuoke
Journal:  Int J Nephrol Renovasc Dis       Date:  2017-08-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.